COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,609 Articles (22,913 medRxiv, 8,696 bioRxiv)

Most recent first Previous |  Page 2824: Articles 28231-28240  | Next

Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies
Matushek, S., Beavis, K. G., Abeleda, A., Bethel, C., Hunt, C., Gillen, S., Moran, A., Tesic, V.
10.1101/2020.05.11.089862 — Posted: 2020-05-13
Planning phase-2 for the endoscopic units in Northern Italy after COVID-19 lockdown: an exit strategy with a lot of critical issues and a few opportunities.
Manes, G., Repici, a., Radaelli, F., Saibeni, S., Bezzio, C., Colombo, M., Pace, F.
10.1101/2020.05.12.20092270 — Posted: 2020-05-13
Characterization of SARS-CoV-2 viral diversity within and across hosts
Sashittal, P., Luo, Y., Peng, J., El-Kebir, M.
10.1101/2020.05.07.083410 — Posted: 2020-05-13
SARS-CoV-2 receptor networks in diabetic kidney disease, BK-Virus nephropathy and COVID-19 associated acute kidney injury
Menon, R., Otto, E. A., Sealfon, R., Nair, V., Wong, A. K., Theesfeld, C. L., Chen, X., Wang, Y., Boppanna, A., Kasson, P. M., Schaub, J. A., Berthier, C. C., Eddy, S., Lienczewski, C. C., Godfrey, B., Dagenais, S. L., Sohaney, R., Hartman, J., Fermin, D., Subramanian, L., Looker, H. C., Mariani, L. H., Naik, A. S., Nelson, R. G., Troyanskaya, O. G., Kretzler, M.
10.1101/2020.05.09.20096511 — Posted: 2020-05-13
Studying the progress of COVID-19 outbreak in India using SIRD model
Chatterjee, S., Sarkar, A., Chatterjee, S., Karmakar, M., Paul, R.
10.1101/2020.05.11.20098681 — Posted: 2020-05-13
Lifestyle Risk Factors for Cardiovascular Disease in Relation to COVID-19 Hospitalization: A Community-Based Cohort Study of 387,109 Adults in UK
Hamer, M., Kivimaki, M., Gale, C. R., Batty, G. D.
10.1101/2020.05.09.20096438 — Posted: 2020-05-13
Increased levels of anxiety among medical and non-medical university students during the COVID-19 pandemic in the United Arab Emirates.
Saddik, B., Hussein, A., Sharif-Askari, F. S., Kheder, W., Temsah, M.-H., Koutaich, R. A., Haddad, E. S., Al-Roub, N. M., Marhoon, F. A., Hamid, Q., Halwani, R.
10.1101/2020.05.10.20096933 — Posted: 2020-05-13 Discussion: Onsite
The Coronavirus 2019 pandemic in Canada: the impact of public health interventions on the course of the outbreak in Alberta and other provinces
Mahsin, M., Lee, S., Vickers, D., Guigue, A., Williamson, T., Quan, H., Quinn, R. R., Ravani, P.
10.1101/2020.05.09.20096636 — Posted: 2020-05-13
Modelling the evolution of COVID-19 in high-incidence European countries and regions: estimated number of infections and impact of past and future intervention measures
Fernandez-Recio, J.
10.1101/2020.05.09.20096735 — Posted: 2020-05-13
A Continuously Active Antimicrobial Coating effective against Human Coronavirus 229E
Ikner, L. A., Torrey, J. R., Gundy, P. M., Gerba, C. P.
10.1101/2020.05.10.20097329 — Posted: 2020-05-13 Discussion: Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).